Relief of symptoms of advanced thromboangiitis obliterans (Buerger's disease) w/ critical limb ischemia in cases where revascularization is not indicated. Relief of symptoms of severe peripheral arterial occlusive disease (PAOD stage III, IV), particularly those at risk of amputation & in whom surgery or angioplasty is not possible. Relief of symptoms of severe disabling Raynaud's phenomenon unresponsive to other therapies.